Depo-subQ 104

DRUG2 trials

Sponsors

FHI 360, Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Contraception

Phase 1

Lower Dose Depo Provera® Contraceptive Injection

CompletedNCT02732418

FHI 360Contraception

Start: 2016-12-02End: 2018-05-15Updated: 2018-06-14

A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046

CompletedNCT03700658

Teva Branded Pharmaceutical Products R&D, Inc.Contraception

Start: 2019-01-15End: 2020-10-02Updated: 2022-01-26